Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Joshua I. Halpern
Advertisement
Articles by Joshua I. Halpern
Advertisement
Latest Updated Articles
- Forecasting Returns When Patents Expire
April 8th 2011
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: UPS's Cold Chain Buildout and AbbVie's $10.9B Immunology Bet
2
Roundtable: Patient Services Leaders on the Pressures Shaping Hubs in 2026
3
Cate Lockhart On Data Sources and the Future of AI in RWE Evaluation
4
What the USMCA Joint Review Means for Pharma
5